Black Rock Inc. Aquestive Therapeutics, Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AQST
# of Institutions
98Shares Held
42.7MCall Options Held
271KPut Options Held
212K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$47.5 Million100.0% of portfolio
-
Vr Adviser, LLC New York, NY5.56MShares$26.9 Million1.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.23MShares$20.5 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA2.85MShares$13.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.58MShares$7.63 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $258M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...